Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort

Journal of Autoimmunity

Volumn 69, Issue , 2016, Pages 59-63

  Kalyoncu, Umut ^a   Solmaz, Dilek ^b   Emmungil, Hakan ^c   Yazici, Ayten ^d   Kasifoglu, Timucin ^e   Kimyon, Gezmiş ^f   Balkarli, Ayşe ^g   Bes, Cemal ^h   Ozmen, Mustafa ⁱ   Alibaz Oner, Fatma ^t   Erten, Sükran ^k   Cagatay, Yonca ^l   Cetin, Gözde Yildirim ^m   Yilmaz, Sedat ⁿ   Yildiz, Fatih ^o   Pamuk, Omer Nuri ^p   Kucuksahin, Orhan ^q   Kilic, Levent ^a   Yazisiz, Veli ^r   Karadag, Omer ^a   Koca, Süleyman Serdar ^s   Hayran, Mutlu ^a   Akar, Servet ^b   Aksu, Kenan ^c   Akkoc, Nurullah ^b   Keser, Gokhan ^c   Gonullu, Emel ^e   Kisacik, Bunyamin ^f   Onat, Ahmet Mesut ^f   Soy, Mehmet ^h   Inanc, Nevsun ^j   Direskeneli, Haner ^j   Sayarlioglu, Mehmet ^m   Erken, Eren ^o   Turgay, Murat ^q   Cefle, Ayse ^d   Ertenli, Ihsan ^a   Pay, Salih ⁿ   more..

^a HACETTEPE UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d KOCAELI UNIVERSITY   (Turkey)

^e OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^f GAZIANTEP UNIVERSITY   (Turkey)

^g PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^h ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

ⁱ ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^k YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^l ISTANBUL BILIM UNIVERSITY   (Turkey)

^m KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

ⁿ GULHANE SCHOOL OF MEDICINE   (Turkey)

^o CUKUROVA UNIVERSITY   (Turkey)

^p TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^q ANKARA UNIVERSITY   (Turkey)

^r AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^s FIRAT UNIVERSITY   (Turkey)

^t NONE

more..

Author keywords

Adult onset Still's disease; Disease modifying anti rheumatic drugs; Disease pattern; Remission

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ADULT; ADULT ONSET STILL DISEASE; ARTHRALGIA; ARTHRITIS; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DELAYED DIAGNOSIS; DRUG MEGADOSE; FEMALE; FEVER; FOLLOW UP; HEPATOMEGALY; HUMAN; LABORATORY TEST; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; MYALGIA; ONSET AGE; OUTCOME ASSESSMENT; PERICARDITIS; PLEURISY; PRIORITY JOURNAL; RASH; REMISSION; SORE THROAT; SPLENOMEGALY; TREATMENT FAILURE; TREATMENT RESPONSE; ADOLESCENT; AGED; CLINICAL TRIAL; COMBINATION DRUG THERAPY; MIDDLE AGED; PHENOTYPE; RECURRENT DISEASE; RISK FACTOR; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; DELAYED DIAGNOSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84960153857     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.02.010     Document Type: Article

References (13)

1. Bywaters E.G. Still's disease in the adult. Ann. Rheum. Dis. 1971, 30:121-133.
2. Gerfaud-Valentin M., Jamilloux Y., Iwaz J., Seve P. Adult-onset Still's disease. Autoimmun. Rev. 2014, 13:708-722.
3. Magadur-Joly G., Billaud E., Barrier J.H., Pennec Y.L., Masson C., Renou P., Prost A. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann. Rheum. Dis. 1995, 54:587-590.
4. Wakai K., Ohta A., Tamakoshi A., Ohno Y., Kawamura T., Aoki R., Kojima M., Lin Y., Hashimoto S., Inaba Y., Minowa M., Aizawa S., Ichikawa Y., Miyasaka N. Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. J. Epidemiol. 1997, 7:221-225.
5. Evensen K.J., Nossent H.C. Epidemiology and outcome of adult-onset Still's disease in Northern Norway. Scand. J. Rheumatol. 2006, 35:48-51.
6. Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., Kashiwazaki S., Tanimoto K., Matsumoto Y., Ota T. Preliminary criteria for classification of adult Still's disease. J. Rheumatol. 1992, 19:424-430.
7. Gerfaud-Valentin M., Maucort-Boulch D., Hot A., Iwaz J., Ninet J., Durieu I., Broussolle C., Sève P. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine 2014, 93:91-99.
8. Fujii T., Akizuki M., Kameda H., Matsumura M., Hirakata M., Yoshida T., Shinozawa T., Mimori T. Methotrexate treatment in patients with adult onset Still's disease-retrospective study of 13 Japanese cases. Ann. Rheum. Dis. 1997, 56:144-148.
9. Fautrel B., Borget C., Rozenberg S., Meyer O., Le Loët X., Masson C., Koeger A.C., Kahn M.F., Bourgeois P. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J. Rheumatol. 1999, 26:373-378.
10. Marchesoni A., Ceravolo G.P., Battafarano N., Rossetti A., Tosi S., Fantini F. Cyclosporin A in the treatment of adult onset Still's disease. J. Rheumatol. 1997, 24:1582-1587.
11. Al-Homood I.A. Biologic treatments for adult-onset Still's disease. Rheumatology 2014, 53:32-38.
12. Ortiz-Sanjuán F., Blanco R., Riancho-Zarrabeitia L., Castañeda S., Olivé A., Riveros A., Velloso-Feijoo M.L., Narváez J., Jiménez-Moleón I., Maiz-Alonso O., Ordóñez C., Bernal J.A., Hernández M.V., Sifuentes-Giraldo W.A., Gómez-Arango C., Galíndez-Agirregoikoa E., Blanco-Madrigal J., Ortiz-Santamaria V., Del Blanco-Barnusell J., De Dios J.R., Moreno M., Fiter J., Riscos Mde L., Carreira P., Rodriguez-Valls M.J., González-Vela M.C., Calvo-Río V., Loricera J., Palmou-Fontana N., Pina T., Llorca J., González-Gay M.A. Efficacy of anakinra in refractory adult-onset Still's disease: multicenter study of 41 patients and literature review. Medicine 2015, 94:e1554.
13. Ortiz-Sanjuán F., Blanco R., Calvo-Rio V., Narvaez J., Rubio Romero E., Olivé A., Castañeda S., Gallego Flores A., Hernández M.V., Mata C., Ros Vilamajo I., Sifuentes Giraldo W.A., Caracuel M.A., Freire M., Gómez Arango C., Llobet J., Manrique Arija S., Marras C., Moll-Tuduri C., Plasencia-Rodriguez C., Roselló R., Urruticoechea A., Velloso-Feijoo M.L., Del Blanco J., González-Vela M.C., Rueda-Gotor J., Pina T., Loricera J., González-Gay M.A. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients. Arthritis Rheumatol. 2014, 66:1659-1665.